Stocktoria
MCKESSON CORP MCK
NYSE · stock · Wholesale-Drugs, Proprietaries & Druggists' Sundries · website · IPO 1994-11-10 · LEI
MCKESSON CORP financials (annual)
Bars are annual figures from 2017 to 2026; red bars are negative (a loss or cash outflow).
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $403.4B | $359.1B | $309.0B | $276.7B | $264.0B | $238.2B | $231.1B | $214.3B | $208.4B | $198.5B |
| Gross profit | $14.6B | $13.3B | $12.8B | $12.4B | $13.1B | $12.1B | $12.0B | $11.8B | $11.2B | $11.3B |
| R&D expense | — | — | — | — | — | — | $96.0M | $71.0M | $125.0M | $341.0M |
| SG&A expense | $8.1B | $8.5B | $8.7B | $7.8B | $10.5B | $8.8B | $9.2B | $8.4B | $8.1B | $7.4B |
| Operating income | $6.2B | $4.4B | $3.9B | $4.4B | $2.0B | -$5.0B | $2.5B | $886.0M | $762.0M | $7.1B |
| Interest expense | — | — | $252.0M | $248.0M | $178.0M | $217.0M | $249.0M | $264.0M | $283.0M | — |
| Income tax | $1.1B | $878.0M | $629.0M | $905.0M | $636.0M | -$695.0M | $18.0M | $356.0M | -$53.0M | $1.6B |
| Net income | $4.8B | $3.3B | $3.0B | $3.6B | $1.1B | -$4.5B | $900.0M | $34.0M | $67.0M | $5.1B |
| EPS (diluted) | $38.38 | $25.72 | $22.39 | $25.03 | $7.23 | $-28.26 | $4.95 | $0.17 | $0.32 | $22.73 |
| Operating cash flow | $6.2B | $6.1B | $4.3B | $5.2B | $4.4B | $4.5B | $4.4B | $4.0B | $4.3B | $4.7B |
| Free cash flow | $5.7B | $5.5B | $3.9B | $4.8B | $4.0B | $4.1B | $4.0B | $3.6B | $3.9B | $4.3B |
| Cash & equivalents | $4.0B | $5.7B | $4.6B | $4.7B | $3.5B | $6.3B | $4.0B | $3.0B | $2.7B | $2.8B |
| Inventory | $24.2B | $23.0B | $21.1B | $19.7B | $18.7B | $19.2B | $16.7B | $16.7B | $16.3B | $15.3B |
| Total assets | $82.3B | $75.1B | $67.4B | $62.3B | $63.3B | $65.0B | $61.2B | $59.7B | $60.4B | $61.0B |
| Shareholders' equity | -$2.2B | -$2.1B | -$2.0B | -$1.9B | -$2.3B | $175.0M | $5.3B | $8.3B | $10.1B | $11.3B |
Growth · year-over-year · Revenue CAGR 8.2%
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +12.4% | +16.2% | +11.7% | +4.8% | +10.8% | +3.1% | +7.8% | +2.9% | +4.9% | +4.0% |
| Net income growth | +44.5% | +9.8% | -15.7% | +219.6% | — | -604.3% | +2547.1% | -49.3% | -98.7% | +124.5% |
| EPS growth | +49.2% | +14.9% | -10.5% | +246.2% | — | -670.9% | +2811.8% | -46.9% | -98.6% | +134.3% |
| Free cash flow growth | +3.1% | +42.9% | -18.6% | +17.9% | -1.1% | +2.0% | +11.1% | -8.4% | -9.2% | +36.3% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2026-03-31. Facts plus Stocktoria's own computed scores — not investment advice.